Early-onset antibody-mediated rejection caused by De Novo HLA class II donor-specific antibody after ABO-compatible liver transplantation: A case report (TTS 2026) - Sep 17, 2026 - Abstract #P2.276; Pres time: Sep 22, 2026; 04:45 PM - 06:00 PM; Location: Hall 1-2; P2; "This case illustrates that de novo HLA class II DSA-induced AMR can occur early after LT, presenting with variable clinical manifestations and posing significant therapeutic challenges. While antibody-directed therapies such as plasmapheresis and rituximab can be effective, disease course may remain unpredictable, and management requires careful adjustment of immunosuppressive regimens."
Case report • Clinical • Alopecia • Antibody-mediated Rejection • Hepatology • Liver Failure • Transplant Rejection • Transplantation
|